# NASCOP ART Guidelines Agent

A specialized AI agent focused exclusively on providing information from Kenya's National AIDS and STI Control Programme (NASCOP) Antiretroviral Therapy (ART) guidelines.

## Purpose

This agent was developed to serve healthcare workers, policy makers, researchers, and other stakeholders who need quick and accurate access to Kenya's official ART guidelines without the need to navigate through lengthy documents or websites.

## Features

- **Specialized Knowledge Base**: Exclusively on NASCOP's ART guidelines
- **Cost-Effective**: Focuses only on ART guidelines to minimize operational costs
- **Clear Boundaries**: Will politely decline to answer questions outside its scope

## Usage Guidelines

### Appropriate Queries

The agent is designed to answer questions such as:
- Current ART regimen recommendations for different patient populations
- Guidelines on ART initiation, monitoring, and switching
- Drug interaction considerations in ART
- Management of treatment failure
- Adherence support strategies
- Special considerations for pediatric patients, pregnant women, etc.

### Limitations

The agent will not respond to:
- General HIV/AIDS questions outside ART guidelines
- General Medical advice
- Non-NASCOP guidelines or international protocols
- Any topic unrelated to NASCOP ART guidelines

## Disclaimer

This agent provides information based solely on NASCOP ART guidelines. It is not a substitute for professional medical advice. NASCOP is not liable for any actions taken based on this information. Always consult with healthcare professionals for diagnosis, treatment, and personalized guidance.

## Technical Implementation

The agent operates with the following instruction parameters:

```
Core Knowledge & Data Access:
- This agent specializes exclusively in providing information from the latest NASCOP Antiretroviral Therapy (ART) guidelines for Kenya.
- The agent will only respond to queries directly related to ART guidelines, protocols, and best practices as defined by NASCOP.
- For questions outside the scope of NASCOP ART guidelines, the agent will politely decline to answer and remind users of its specific focus.
- To minimize costs, the agent will not process or respond to queries about other HIV/AIDS topics, general medical advice, or non-NASCOP information.
```

## Contributing

Contributions to improve the agent's knowledge base or functionality are welcome. Please ensure that any additions are based on official NASCOP publications.

## License

This project is licensed under the MIT License - see below for details:

```
MIT License

Copyright (c) 2025 National AIDS/STIs Control Programme

Permission is hereby granted, free of charge, to any person obtaining a copy
of this software and associated documentation files (the "Software"), to deal
in the Software without restriction, including without limitation the rights
to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
copies of the Software, and to permit persons to whom the Software is
furnished to do so, subject to the following conditions:

The above copyright notice and this permission notice shall be included in all
copies or substantial portions of the Software.

THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
SOFTWARE.
```

## Contact

siri@nascop.org
